The model is straightforward: all-inclusive subscription pricing, both molecules available (semaglutide by injection or sublingual tablet, tirzepatide as an oral tablet), comprehensive medical oversight, no add-ons or upsells in the standard plan
Consumers should verify all current details directly with FeelGood at feelgoodmeds.com before enrollment
In TRIUMPH-4, the first Phase 3 trial to report results (December 2025), participants on the 12mg dose lost an average of 28.7% of body weight at 68 weeks, about 71 pounds
So heres what they say - What Do the Numbers Actually Say
Animal experiments included data from both male and female animals
Metformin, a biguanide, has been a cornerstone of type 2 diabetes pharmacotherapy for decades, with an established safety profile and extensive clinical experience